Статья: Острая ревматическая лихорадка и ревматическая болезнь сердца: что нового? (2023)

Watkins D.A., Johnson C.O., Colquhoun S.M. et al. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015. N Engl J Med 2017;377(8):713-22. DOI: 10.1056/NEJMoa1603693 EDN: ZTVZVD

Meira Z.M., Goulart E.M., Colosimo E.A., Mota C.C. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 2005;91(8):1019-22. DOI: 10.1136/hrt.2004.042762

Longo-Mbenza B., Bayekula M., Ngiyulu R. et al. Survey of rheumatic heart disease in school children of Kinshasa town. Int J Cardiol 1998;63(3):287-94. DOI: 10.1016/s0167-5273(97)00311-2 EDN: AAUVIZ

Watkins D.A., Beaton A.Z., Carapetis J.R. et al. Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel. J Am Coll Cardiol 2018;72(12):1397-416. DOI: 10.1016/j.jacc.2018.06.063 EDN: DDYSBS

Doukky R., Abusin S.A., Bayissa Y.A. et al. Rheumatic heart disease in modern urban America: a cohort study of immigrant and indigenous patients in Chicago. Int J Cardiol 2014;175(1):178-80. DOI: 10.1016/j.ijcard.2014.04.207

Rothenbuhler M., O’Sullivan C.J., Stortecky S. et al. Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. Lancet Glob Health 2014;2(12):e717-26. DOI: 10.1016/S2214-109X(14)70310-9 EDN: USHHQV

Carapetis J.R., Zuhlke L.J. Global research priorities in rheumatic fever and rheumatic heart disease. Ann Pediatr Cardiol 2011;4(1):4-12. DOI: 10.4103/0974-2069.79616

Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation 1985;72(6):1155-62. DOI: 10.1161/01.cir.72.6.1155

Massell B.F., Chute C.G., Walker A.M., Kurland G.S. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N Engl J Med 1988;318(5):280-6. DOI: 10.1056/NEJM198802043180504

EXPERT committee on rheumatic diseases; first report. World Health Organ Tech Rep Ser 1954;78:1-25. PMID: 13157434.  PMID: 13157434  	 

Bach J.F., Chalons S., Forier E. et al. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet 1996;347(9002):644-8.  DOI: 10.1016/s0140-6736(96)91202-7  EDN: CEEYGJ  

Nordet P., Lopez R., Duenas A., Sarmiento L. Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986-1996-2002). Cardiovasc J Afr 2008;19(3): 135-40. PMID: 18568172.  PMID: 18568172   

Gunther G., Asmera J., Parry E. Death from rheumatic heart disease in rural Ethiopia. Lancet 2006;367(9508):391.  DOI: 10.1016/S0140-6736(06)68128-2 	 

Colquhoun S.M., Condon J.R., Steer A.C. et al. Disparity in mortality from rheumatic heart disease in indigenous Australians. J Am Heart Assoc 2015;4(7):e001282.  DOI: 10.1161/JAHA.114.001282	 

Parks T., Kado J., Miller A.E. et al. Rheumatic heart disease-attributable mortality at ages 5-69 years in Fiji: a five-year, national, population-based record-linkage cohort study. PloS Negl Trop Dis 2015;9(9):e0004033.  DOI: 10.1371/journal.pntd.0004033  EDN: VFHDIZ  

Maurice J. Rheumatic heart disease back in the limelight. Lancet 2013;382(9898):1085-6.  DOI: 10.1016/s0140-6736(13)61972-8  	 

Marijon E., Ou P., Celermajer D.S. et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007;357(5):470-6.  DOI: 10.1056/NEJMoa065085   

Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Geneva: World Health Organization, 2013. Available at: https://apps.who.int>iris/handle/10665/94384.  	 

Remenyi B., Carapetis J., Wyber R. et al. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol 2013;5(10):284-92.  DOI: 10.1038/nrcardio.2013.34  EDN: RHHQKH  	

Francis J.R., Gargan C., Remenyi B. et al. A cluster of acute rheumatic fever cases among Aboriginal Australians in a remote community with high baseline incidence. Aust NZJ Public Health 2019;43(3):288-93.  DOI: 10.1111/1753-6405.12893  	 

Pastore S., De Cunto A., Benettoni A. et al. The resurgence of rheumatic fever in a developed country area: the role of echocardiography. Rheumatology (Oxford) 2011;50(2):396-400.  DOI: 10.1093/rheumatology/keq290  

Veasy L.G., Wiedmeier S.E., Orsmond G.S. et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987;316(4):421-7.  DOI: 10.1056/NEJM198702193160801  

Kumar R.K., Tandon R. Rheumatic fever & rheumatic heart disease: the last 50 years. Indian J Med Res 2013;137(4):643-58. PMID: 23703332.  PMID: 23703332  	 

Кузьмина Н.Н., Медынцева Л.Г., Белов Б.С. Ревматическая лихорадка: полувековой опыт изучения проблемы. Размышления ревматолога. Научно-практическая ревматология 2017;55(2):125-37.  DOI: 10.14412/1995-4484-2017-125-137  EDN: YSTSPF  

Заболеваемость населения России в 2014 г. Статистические материалы. М., 2015. 

Аксенова А.В., Абельдяев Д.В., Глушкова Е.В. Эпидемиологические аспекты стрептококковых и постстрептококковых заболеваний в Российской Федерации на современном этапе. Клиницист 2020;14(1-2):14-23.  DOI: 10.17650/1818-83382020-14-1-2-14-23  EDN: TPSJXC  

Gewitz M.H., Baltimore R.S., Tani L.Y. et al. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography: a scientific statement from the American Heart Association. Circulation 2015;131(20):1806-18.  DOI: 10.1161/CIR.0000000000000205   

Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation, Geneva, 29 October - 1 November 2001. Geneva: World Health Organization, 2004. Available at: https://apps.who.int/iris/handle/10665/42898.  

Tubridy-Clark M., Carapetis J.R. Subclinical carditis in rheumatic fever: a systematic review. Int J Cardiol 2007;119(1):54-8.  DOI: 10.1016/j.ijcard.2006.07.046  

Zuhlke L., Engel M.E., Karthikeyan G. et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J 2015;36(18):1115-22a.  DOI: 10.1093/eurheartj/ehu449  EDN: USIEDV  	

Wilson N.J., Voss L., Morreau J. et al. New Zealand guidelines for the diagnosis of acute rheumatic fever: small increase in the incidence of definite cases compared to the America Heart Association Jones criteria. N Z Med J 2013;126(1379):50-9. PMID: 24045352.  PMID: 24045352  	 

Remenyi B., Wilson N., Steer A. et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease: an evidence-based guideline. Nat Rev Cardiol 2012;9(5):297-309.  DOI: 10.1038/nrcardio.2012.7  EDN: HWABGR  

Watkins D., Beaton A. Carapetis J.R. et al. Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel. J Am Coll Cardiol 2018;72(12):1397-416.  DOI: 10.1016/j.jacc.2018.06.063  EDN: DDYSBS  	

Abernethy M., Bass N., Sharpe N. et al. Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever. Aust N Z J Med 1994;24(5):530-5.  DOI: 10.1111/j.1445-5994.1994.tb01753.x  	 

Minich L.L., Tani L.Y., Pagotto L.T. et al. Doppler echocardiography distinguishes between physiologic and pathologic "silent" mitral regurgitation in patients with rheumatic fever. Clin Cardiol 1997;20(11):924-6.  DOI: 10.1002/clc.4960201105  	 

World Health Organization. WHA71.14: Rheumatic Fever and Rheumatic Heart Disease. 2018. Available at: https://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_R14-en.pdf.  

Watkins D.A., Sebitloane M., Engel M.E., Mayosi B.M. The burden of antenatal heart disease in South Africa: a systematic review. BMC Cardiovasc Disord 2012;12:23.  DOI: 10.1186/1471-2261-12-23  EDN: NDBESB  

Anthony J., Osman A., Sani M.U. Valvular heart disease in pregnancy. Cardiovasc J Afr 2016;27(2):111-8.  DOI: 10.5830/CVJA-2016-052  EDN: YENOTT  	

van Hagen I.M., Thorne S.A., Taha N. et al. Pregnancy outcomes in women with rheumatic mitral valve disease: results from the Registry of Pregnancy and Cardiac Disease. Circulation 2018;137(8):806-16.  DOI: 10.1161/CIRCULATIONAHA.117.032561  EDN: YHXCDR  

Rezk M., Elkilani O., Shaheen A. et al. Maternal hemodynamic changes and predictors of poor obstetric outcome in women with rheumatic heart disease: a five-year observational study. J Matern Fetal Neonatal Med 2018:131(12):1542-7.  DOI: 10.1080/14767058.2017.1319932  

Diao M., Kane A., Ndiaye M.B. et al. Pregnancy in women with heart disease in sub-Saharan Africa. Arch Cardiovasc Dis 2011;104(6-7):370-4.  DOI: 10.1016/j.acvd.2011.04.001  	 

Otto H., Saether S.G., Banteyrga L. et al. High prevalence of sub-clinical rheumatic heart disease in pregnant women in a developing country: an echocardiographic study. Echocardiography 2011;28(10):1049-53.  DOI: 10.1111/j.1540-8175.2011.01520.x  

D'Souza R., Ostro J., Shah P.S. et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J 2017;389190:1509-16.  DOI: 10.1093/eurheartj/ehx032  

Xu Z., Fan J., Luo X. et al. Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and meta-analysis. Can J Cardiol 2016;32(10):1248.e1-9.  DOI: 10.1016/j.cjca.2015.11.005  	 

French K.A., Poppas A. Rheumatic heart disease in pregnancy: global challenges and clear opportunities. Circulation 2018;137(8): 817-9.  DOI: 10.1161/CIRCULATIONAHA.118.033465  EDN: OHHTLK